In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, provides a nursing-focused overview on available BTK inhibitors in the treatment of CLL and lymphomas. Topics in this podcast include:
- Rationale for inhibiting BTK
- MOA of BTK inhibitors
- Approved BTK inhibitors
- Recent clinical trial findings
Link to full program, including downloadable slidesets:
https://bit.ly/3iwN9Ub
Presenter:
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Nurse Practitioner
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Decera Clinical Education Oncology Podcast